Cart
sales@molnova.com
Trimethobenzamide hydrochloride
CAS No. 554-92-7
Trimethobenzamide hydrochloride( Ro 2-9578 | Tribenzagan Hydrochloride )
Catalog No. M19813 CAS No. 554-92-7
Trimethobenzamide hydrochloride is a blocker of the D2 receptor. Trimethobenzamide is an antiemetic used to prevent nausea and vomiting.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 37 | In Stock |
|
| 25MG | 37 | In Stock |
|
| 50MG | 50 | In Stock |
|
| 100MG | 75 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 154 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTrimethobenzamide hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionTrimethobenzamide hydrochloride is a blocker of the D2 receptor. Trimethobenzamide is an antiemetic used to prevent nausea and vomiting.
-
DescriptionTrimethobenzamide hydrochloride is a blocker of the D2 receptor. Trimethobenzamide is an antiemetic used to prevent nausea and vomiting.(In Vitro):Trimethobenzamide is a (non-phenothiazine) benzamide antiemetic that acts centrally to block D2 receptors, thereby inhibiting the medullary chemoreceptor trigger zone by blocking emetic impulses to the vomiting center.(In Vivo):The oral bioavailability of Trimethobenzamide is 60% to 100%. The time to peak is about 45 minutes after oral administration and; Intramuscular (I.M.) administration about 30 minutes after intramuscular administration.
-
In VitroTrimethobenzamide is a (non-phenothiazine) benzamide antiemetic that acts centrally to block D2 receptors, thereby inhibiting the medullary chemoreceptor trigger zone by blocking emetic impulses to the vomiting center.
-
In VivoThe oral bioavailability of Trimethobenzamide is 60% to 100%. The time to peak is about 45 minutes after oral administration and; Intramuscular (I.M.) administration about 30 minutes after intramuscular administration.
-
SynonymsRo 2-9578 | Tribenzagan Hydrochloride
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorD2
-
Research AreaOthers
-
IndicationNausea and vomiting
Chemical Information
-
CAS Number554-92-7
-
Formula Weight424.92
-
Molecular FormulaC21H29ClN2O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:≥100 mg/mL (235.34 mM)
-
SMILESCl.COc1cc(cc(OC)c1OC)C(=O)NCc1ccc(OCCN(C)C)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Smith HS et al. Dopamine receptor antagonists. Ann Palliat Med. 2012 Jul;1(2):137-42.
molnova catalog
related products
-
Mesdopetam hemitartr...
Mesdopetam hemitartrate is an antagonist of dopamine D3 receptor (Ki=90 nM; IC50=9.8 μM for human recombinant D3 receptor).
-
UNC9975
UNC9975 is a beta-inhibitory protein-biased dopamine D(2) receptor agonist with antipsychotic activity and can be used to study neurologic disorders such as schizophrenia.
-
Veralipride
Veralipride is an antagonist of D2 receptor.
